How Nandrolone Decanoate (Deca) Affects Prolactin

Nandrolone (Deca-Durabolin) is a 19-nortestosterone (19-nor) derivative that increases prolactin through several interrelated mechanisms:

1. Progesterone receptor agonism: Nandrolone and its metabolites (particularly 5-alpha-dihydronandrolone) have significant affinity for the progesterone receptor. Progesterone receptor activation stimulates prolactin gene expression in the anterior pituitary lactotroph cells.
2. Dopamine pathway modulation: Prolactin secretion is tonically inhibited by dopamine from the tuberoinfundibular pathway. 19-nor compounds may reduce dopaminergic tone through mechanisms that are not fully characterised, partially releasing the brake on prolactin secretion.
3. Estrogen interaction: While nandrolone aromatises less than testosterone, it does produce some estradiol and estrone. Estrogen stimulates prolactin secretion by enhancing lactotroph sensitivity. When nandrolone is stacked with testosterone (standard practice), the combined estrogenic activity can further elevate prolactin.
4. Duration of exposure: Nandrolone decanoate has a long half-life (approximately 6-12 days), meaning the prolactin-elevating stimulus is continuous and sustained, allowing prolactin to accumulate over weeks.

The prolactin elevation from nandrolone is the primary mechanism behind "deca dick," the well-known sexual dysfunction associated with this compound.

Low to moderate doses (200-300 mg/week):

• Prolactin may rise 50-100% above baseline
• A baseline prolactin of 10 ng/mL might rise to 15-20 ng/mL
• Many users remain asymptomatic at this level
• Upper normal limit is approximately 15-25 ng/mL depending on the lab

Standard bodybuilding doses (400-600 mg/week):

• Prolactin commonly rises 100-300% above baseline
• Values of 25-50 ng/mL are typical
• Sexual dysfunction (low libido, erectile difficulty) becomes common at this range
• Nipple sensitivity or discharge may occur

High doses or prolonged use (600+ mg/week or cycles exceeding 16 weeks):

• Prolactin can exceed 50-100 ng/mL
• Pronounced sexual dysfunction is nearly universal
• Gynecomastia risk increases (prolactin-mediated, distinct from estrogen-mediated gynecomastia)
• Mood disturbances: depression, anxiety, anhedonia

Timeline: Prolactin elevation develops gradually over 3-6 weeks. The onset is slower than estradiol changes because it depends on cumulative progesterone receptor activation and dopaminergic modulation. Peak prolactin levels are typically reached at 6-10 weeks.

Baseline: Check prolactin before starting nandrolone. Elevated baseline prolactin (above 20 ng/mL) should be investigated before introducing a compound that will raise it further.

During use: Check prolactin at week 4-6 and again at week 10-12. The slow, cumulative nature of nandrolone's prolactin effect means early checks may underestimate the eventual peak.

Symptom-driven testing: If sexual dysfunction, nipple sensitivity, or mood changes develop, check prolactin promptly regardless of the scheduled timing.

Important: Always check both prolactin AND estradiol. The symptoms of high prolactin and high estradiol overlap significantly (sexual dysfunction, gynecomastia, mood changes). Treatment differs depending on which is elevated. Some users have both elevated simultaneously.

Post-cycle: Prolactin should be rechecked 4-6 weeks after the last nandrolone injection. Due to nandrolone decanoate's long half-life, prolactin may remain elevated for several weeks after the last dose.

Prevention:

• Keep nandrolone doses moderate (300-400 mg/week provides excellent anabolic effects with less prolactin elevation)
• Some users prophylactically use low-dose cabergoline (0.25 mg twice weekly) when running nandrolone, though this is debated
• Vitamin B6 (P5P form) 50-100 mg/day may provide mild dopamine support, though evidence is limited at physiological prolactin-lowering doses

If prolactin is elevated with symptoms:

• Cabergoline 0.25-0.5 mg twice weekly is the first-line treatment
• Cabergoline is a potent, long-acting dopamine D2 receptor agonist that reliably suppresses prolactin
• Start at 0.25 mg twice weekly and increase if prolactin remains elevated after 4 weeks
• Effects on prolactin are rapid; most users notice symptom improvement within 1-2 weeks

If prolactin is mildly elevated without symptoms:

• Monitoring alone is reasonable
• Not all prolactin elevation requires treatment; some men tolerate levels of 25-30 ng/mL without sexual dysfunction
• Treat the patient, not the number

Cabergoline cautions:

• Do not exceed 1 mg twice weekly without medical supervision
• Very high doses (above 2 mg/week, used in some pituitary adenoma protocols) carry a theoretical risk of cardiac valve fibrosis, though this risk is minimal at bodybuilding doses
• Cabergoline can cause nausea, dizziness, and compulsive behaviour (rare) at higher doses

Alternative to nandrolone: If prolactin management is problematic, consider boldenone (equipoise) as an alternative long-ester injectable. Boldenone does not have significant progestogenic activity and does not elevate prolactin.